Meridian Bioscience Saham

Meridian Bioscience EPS

Laba per Saham (EPS) dari Meridian Bioscience (VIVO) pada 17 Agu 2026 adalah 0,96 USD. Tahun sebelumnya, Laba per Saham (EPS) adalah 1,62 USD — perubahan sebesar -41,03% (lebih rendah).

EPS

0,96USD

YoY

-41,03%

Terakhir Diperbarui:

Laba per Saham (EPS) dari Meridian Bioscience adalah 2026 0,96 USD. Laba per Saham (EPS) dari Meridian Bioscience adalah 2025 1,62 USD. Menurun -41,03% lebih rendah dibandingkan dengan tahun sebelumnya.
Access this data via the Eulerpool API

Meridian Bioscience Analisis saham

Apa yang dilakukan Meridian Bioscience? Meridian Bioscience Inc. is a global company specializing in the development, manufacture, and distribution of test kits for the diagnosis of infectious diseases and other medical conditions. The company was founded in 1976 by William J. Motto and initially focused on the development of enzyme immunoassays (EIA). Over the years, the company has grown and diversified its product offerings, becoming a leading provider of diagnostic test kits for acute and chronic medical conditions, infectious diseases, gastrointestinal infections, and virology. The company's success is attributed to its diverse range of test kits in various medical areas, including immunology, infectious diseases, sexually transmitted diseases, gastroenterology, and virology. Additionally, Meridian Bioscience Inc. stays up-to-date with the latest technological advancements in biotechnology to ensure the fast and effective performance of its tests. The company operates globally, collaborating with universities, research institutions, government agencies, and distributors to ensure the worldwide distribution and marketing of its products. In summary, Meridian Bioscience Inc. is an innovative company specializing in the development, manufacture, and distribution of test kits for the diagnosis of infectious diseases and other medical conditions. Its wide range of products, including immunology products, infectious disease diagnostics, sexually transmitted disease test kits, gastroenterology, virology, and molecular diagnostics, coupled with advanced technologies, provides fast, accurate, and reliable diagnostic support. Meridian Bioscience adalah salah satu perusahaan paling populer di Eulerpool.

Pertanyaan yang Sering Diajukan tentang saham Meridian Bioscience

Laba per Saham (EPS) Meridian Bioscience adalah 0,96 USD pada tahun 2026.

Laba per Saham (EPS) dari Meridian Bioscience berubah dari 1,62 USD menjadi 0,96 USD, mewakili perubahan -41,03%. Nilainya lebih rendah daripada tahun sebelumnya.

Di Eulerpool Anda dapat menemukan perkembangan historis lengkap Laba per Saham (EPS) Meridian Bioscience sejak 2006 – dengan nilai tahunan, bagan, dan analisis detail.

Laba per Saham mengukur porsi laba perusahaan yang dialokasikan untuk setiap saham yang beredar. Metrik ini adalah metrik kunci untuk menilai profitabilitas perusahaan berdasarkan per saham.

EPS = Laba Bersih / Saham yang Beredar

Access this data via the Eulerpool API

Laporan Laba Rugi — Meridian Bioscience

Semua Metrik Kunci — Meridian Bioscience